Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology, Pierre Fabre enter into license agreement to develop and commercialize NERLYNX in Europe - Pharmaceutical Business review
Puma Biotech's Neratinib Fails To Extend Overall Survival In Brain Cancer Trial
PBYI Institutional Ownership - Puma Biotechnology Inc Stock
Puma Biotechnology
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Shares Soar 81% Over 2 Days | Los Angeles Business Journal
In the wake of Puma Biotechnology, Inc.'s (NASDAQ:PBYI) latest US$17m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St News
Puma Biotechnology to Present at the Cantor Virtual Global Healthcare Conference | Business Wire
ICOMPRE 2 DE CADA CAJA puma biotechnology inc Y OBTENGA UN 70% DE DESCUENTO!
Puma Biotechnology
Puma Pharma (@PumaPharma) / Twitter
Puma Biotechnology
Puma Biotechnology Surging
Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2019 SABCS | Business Wire
Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS | Business Wire
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology's NERLYNX® Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer | Business Wire
Puma Biotechnology shares rocket after biopharma zips past Street's 4Q estimate
Puma Biotechnology
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Former Puma Biotechnology exec is accused of making $1.2 million from insider trading - Los Angeles Times
Puma Biotechnology out-licenses Nerlynx in Canada
Puma Biotechnology, Inc. | LinkedIn
